{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:04:49Z","timestamp":1762142689546,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ministry of Education and Science, Serbia","award":["III 41030","ON 172032"],"award-info":[{"award-number":["III 41030","ON 172032"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.ejphar.2012.03.011","type":"journal-article","created":{"date-parts":[[2012,3,17]],"date-time":"2012-03-17T09:30:54Z","timestamp":1331976654000},"page":"93-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The mechanisms responsible for neuroprotective capacity of arylpiperazine dopaminergic ligands against cell death induced by sodium nitroprusside"],"prefix":"10.1016","volume":"683","author":[{"given":"\u0110ur\u0111ica","family":"Ignjatovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danijela","family":"Vojnovi\u0107 Milutinovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Nikoli\u0107-Koki\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Slavi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deana","family":"Andri\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirko","family":"Tomi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sla\u0111ana","family":"Kosti\u0107-Raja\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2012.03.011_bb0005","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jcp.21903","article-title":"p38SJ, a novel DINGG protein protects neuronal cells from alcohol induced injury and death","volume":"221","author":"Amini","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0010","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jnr.10290","article-title":"Protective effects of atypical antipsychotic drugs on PC12 cells after serum withdrawal","volume":"69","author":"Bai","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1586\/14737175.6.1.81","article-title":"Dopamine agonists in the treatment of Parkinson's disease","volume":"6","author":"Bonuccelli","year":"2006","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0020","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1124\/mol.108.048975","article-title":"Reactive oxygen species mediate p53 activation and apoptosis induced by sodium nitroprusside in SH-SY5Y cells","volume":"74","author":"Cardaci","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0025","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0003-2697(86)90131-4","article-title":"Determination of the number of endothelial cells in culture using an acid phosphatase assay","volume":"152","author":"Connolly","year":"1986","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0030","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.neuroscience.2006.11.010","article-title":"Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate","volume":"144","author":"Cui","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2012.03.011_bb0035","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.4161\/cbt.8.12.8561","article-title":"ERK activation increases nitroprusside induced apoptosis in human melanoma cells irrespective of p53 status: role of superoxide dismutases","volume":"8","author":"Gomez-Sarosi","year":"2009","journal-title":"Cancer. Biol. Ther."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0009-8981(98)00060-6","article-title":"Determination of nitrite\/nitrate in human biological material by the simple Griess reaction","volume":"274","author":"Guevara","year":"1998","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0045","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1124\/mol.105.020487","article-title":"Iron released by sodium nitroprusside contributes to heme oxygenase-1 induction via the cAMP-protein kinase A-mitogen-activated protein kinase pathway in RAW 264.7 cells","volume":"69","author":"Kim","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0050","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1124\/mol.54.6.1046","article-title":"Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells","volume":"54","author":"Kitamura","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0055","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI200318182","article-title":"Oxidative stress, cell cycle, and neurodegeneration","volume":"111","author":"Klein","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0060","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/ars.2008.2234","article-title":"Nitric oxide in health and disease of the nervous system","volume":"11","author":"Knott","year":"2009","journal-title":"Antioxid. Redox. Signal."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0065","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0896-6273(00)00061-1","article-title":"Spatially and functionally distinct roles of the PI3-K effector pathway during NGF signaling in sympathetic neurons","volume":"27","author":"Kuruvilla","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2012.03.011_bb0070","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1046\/j.1471-4159.1996.67052208.x","article-title":"Scavenging effects of dopamine agonists on nitric oxide radicals","volume":"67","author":"Nishibayashi","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0075","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0003-2697(90)90113-N","article-title":"A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid","volume":"189","author":"Nordstedt","year":"1990","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0080","doi-asserted-by":"crossref","first-page":"7923","DOI":"10.1523\/JNEUROSCI.22-18-07923.2002","article-title":"Copper\/zinc superoxide dismutase attenuates neuronal cell death by preventing extracellular signal-regulated kinase activation after transient focal cerebral ischemia in mice","volume":"22","author":"Noshita","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0085","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/S1471-1931(00)00030-6","article-title":"Continuous dopamine-receptor stimulation in early Parkinson's disease","volume":"23","author":"Olanow","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0090","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1182\/blood-2004-07-2802","article-title":"Pharmacologic inhibitors of PI3K\/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells","volume":"105","author":"Ramos","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2012.03.011_bb0095","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group","volume":"342","author":"Rascol","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0100","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/j.1471-4159.1980.tb11254.x","article-title":"Peroxidative changes in brain cortical fatty acids and phospholipids, as characterized during Fe2+- and ascorbic acid-stimulated lipid peroxidation in vitro","volume":"34","author":"Rehncrona","year":"1980","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0105","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1124\/mol.104.004077","article-title":"Mechanisms of agonist action at D2 dopamine receptors","volume":"66","author":"Roberts","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0110","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1523\/JNEUROSCI.2111-04.2004","article-title":"Regulation of Cu\/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase\/Akt pathway and nuclear factor-kappaB","volume":"24","author":"Rojo","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bbrc.2008.08.110","article-title":"The Cu\u2013Zn superoxide dismutase (SOD1) inhibits ERK phosphorylation by muscarinic receptor modulation in rat pituitary GH3 cells","volume":"376","author":"Secondo","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0120","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2012.03.011_bb0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cellimm.2009.10.008","article-title":"Prosurvival and proapoptotic functions of ERK1\/2 activation in murine thymocytes in vitro","volume":"261","author":"Smirnova","year":"2010","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ptr.3269","article-title":"Protective effects of dibenzocyclooctadiene lignans from Schisandra chinensis against beta-amyloid and homocysteine neurotoxicity in PC12 cells","volume":"25","author":"Song","year":"2011","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0135","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0003-2697(78)90327-5","article-title":"Refinement of the coomassie blue method of protein quantitation. A simple and linear spectrophotometric assay for less than or equal to 0.5 to 50 microgram of protein","volume":"86","author":"Spector","year":"1978","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0140","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1212\/WNL.62.1_suppl_1.S56","article-title":"Continuous dopaminergic stimulation in early and advanced Parkinson's disease","volume":"62","author":"Stocchi","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2012.03.011_bb0145","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ejmech.2004.10.006","article-title":"Synthesis, dopamine D2 receptor binding studies and docking analysis of 5-[3-(4-arylpiperazin-1-yl)propyl]-1H-benzimidazole, 5-[2-(4-arylpiperazin-1-yl)ethoxy]-1H-benzimidazole and their analogs","volume":"40","author":"\u0160ukalovi\u0107","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0150","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0003-2697(69)90064-5","article-title":"Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues","volume":"27","author":"Tietze","year":"1969","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0165","first-page":"677","article-title":"Pharmacological evaluation of 5-[2-[4-(2-methoxy-phenyl)-piperazin-1-yl]-ethyl]-1,3-dihydro-benzimidazol e-2-thione as a potential atypical antipsychotic agent","volume":"58","author":"Tomi\u0107","year":"2003","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejphar.2012.03.011_bb0160","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1016\/j.bmcl.2004.06.005","article-title":"Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential","volume":"14","author":"Tomi\u0107","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0155","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1016\/j.bmcl.2007.08.066","article-title":"Two new phenylpiperazines with atypical antipsychotic potential","volume":"17","author":"Tomi\u0107","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-2999(01)01537-0","article-title":"Pergolide protects SH-SY5Y cells against neurodegeneration induced by H(2)O(2)","volume":"434","author":"Uberti","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0170","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s11064-007-9350-9","article-title":"Dopaminergic agonists: possible neurorescue drugs endowed with independent and synergistic multisites of action","volume":"32","author":"Uberti","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0180","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/jnr.10668","article-title":"Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide","volume":"73","author":"Wei","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0185","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1471-4159.2001.00233.x","article-title":"Mechanisms of inverse agonism of antipsychotic drugs at the D(2) dopamine receptor: use of a mutant D(2) dopamine receptor that adopts the activated conformation","volume":"77","author":"Wilson","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0190","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12264-007-0018-x","article-title":"Pathogenesis of Parkinson's disease: oxidative stress, environmental impact factors and inflammatory processes","volume":"23","author":"Yuan","year":"2007","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0195","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1124\/jpet.106.107367","article-title":"A death-promoting role for extracellular signal-regulated kinase","volume":"319","author":"Zhuang","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2012.03.011_bb0200","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0304-3940(00)00853-3","article-title":"Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL\/6 mice","volume":"281","author":"Zou","year":"2000","journal-title":"Neurosci. Lett."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912002518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912002518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:01:40Z","timestamp":1762142500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299912002518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":40,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0014299912002518"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2012.03.011","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mechanisms responsible for neuroprotective capacity of arylpiperazine dopaminergic ligands against cell death induced by sodium nitroprusside","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2012.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}